Executive Summary
Two regulatory filings on May 18, 2026 highlight contrasting listing statuses: Palatin Technologies voluntarily delists from NYSE American to transfer to Nasdaq Capital Market, maintaining its symbol PTN, while Synergy CHC Corp. faces a Nasdaq deficiency notice for failing to maintain the $1.00 bid price, with a 180-day cure period until November 11, 2026.
Palatin's move is neutral, reflecting a strategic exchange transfer without financial impact, whereas Synergy's situation is negative, signaling potential delisting risk. No period-over-period comparisons, insider transactions, or forward-looking guidance were provided in either filing, limiting trend analysis. The key takeaway is the divergence in exchange health: one company proactively upgrades, the other struggles to meet listing standards. Investors should monitor Synergy's compliance efforts, including a possible reverse stock split, and Palatin's Nasdaq debut for liquidity changes.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from May 13, 2026.
Investment Signals (2)
- Palatin Technologies ↓ (NEUTRAL)▲
Voluntary transfer to Nasdaq Capital Market from NYSE American, effective May 29, 2026, with same symbol PTN; may improve liquidity and visibility, but no financial data disclosed
- Synergy CHC Corp ↓ (BEARISH)▲
Received Nasdaq deficiency notice for bid price below $1.00; has 180 days until November 11, 2026 to regain compliance; evaluating reverse stock split; high risk of delisting if unsuccessful
Risk Flags (3)
- Synergy CHC Corp / Delisting Risk↓ [HIGH RISK]▼
Nasdaq notice for bid price non-compliance; stock must close at $1.00+ for 10 consecutive days by November 11, 2026; reverse split may be necessary but no guarantee; potential OTC transfer if failed
- Synergy CHC Corp / Dilution Risk↓ [MEDIUM RISK]▼
Reverse stock split evaluation could lead to shareholder dilution and negative market perception; no insider buying reported to signal confidence
- Palatin Technologies / Transfer Risk↓ [LOW RISK]▼
While approved, Nasdaq listing may impose stricter ongoing requirements; no financial metrics provided to assess health; voluntary delisting could indicate strategic shift
Opportunities (2)
- Palatin Technologies / Nasdaq Listing↓ (OPPORTUNITY)◆
Transfer to Nasdaq may attract institutional investors and improve trading liquidity; watch for increased volume post-May 29; no negative insider activity reported
- Synergy CHC Corp / Compliance Catalyst↓ (SPECULATIVE)◆
If company announces credible plan (e.g., reverse split, business update) to regain compliance, stock could rally; monitor for press releases before November 2026 deadline
Sector Themes (1)
- Exchange Listing Volatility◆
Two micro-cap companies face listing status changes on same day; one voluntarily upgrades (Palatin), one faces deficiency (Synergy); highlights binary outcomes for small caps with low share prices
Watch List (3)
-
Nasdaq listing effective May 29, 2026; monitor first-day trading volume and price action for liquidity improvement
-
Compliance deadline November 11, 2026; watch for reverse stock split announcement or business updates; any insider buying would be a positive signal
-
Next earnings call for forward guidance on compliance strategy; no date provided, but likely within 45 days
Filing Analyses
(2)
18-05-2026
Palatin Technologies, Inc. (PTN) announced on May 18, 2026 its voluntary withdrawal from the NYSE American and transfer of its common stock listing to the Nasdaq Capital Market, effective May 29, 2026. The Nasdaq has approved the listing, and the stock will continue trading under the same symbol 'PTN'. NYSE trading will cease at the close on May 28, 2026. No financial impact or performance metrics were disclosed.
- · The voluntary delisting was authorized by the Board of Directors.
- · The transfer to Nasdaq was approved by Nasdaq before the filing.
- · Trading symbol remains PTN.
- · NYSE American trading ceases at close on May 28, 2026.
- · Nasdaq trading begins on May 29, 2026.
18-05-2026
On May 15, 2026, Synergy CHC Corp. received a Nasdaq notice for failure to maintain the minimum $1. bid price of $1.00 per share over 30 consecutive business days. The company has 180 calendar days, until November 11, 2026, to regain compliance by having the closing bid price at $1.00 or higher for at least 10 consecutive business days. The company is evaluating options including a potential reverse stock split, but there is no guarantee of regaining compliance.
- · The notice was received on May 15, 2026.
- · The company has until November 11, 2026 (180 calendar days) to regain compliance.
- · To regain compliance, the stock must close at or above $1.00 per share for at least 10 consecutive business days.
- · If compliance is not regained by November 11, 2026, the company may be eligible for an additional 180-day period if it meets all other initial listing standards except the bid price requirement and provides notice of intent to cure via a reverse stock split.
- · The company trades on The Nasdaq Capital Market under the symbol SNYR.
- · The company's common stock has a par value of $0.00001 per share.
Get daily alerts with 2 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US SEC Trading Suspension Halt Orders
🇺🇸 More from United States
View all →May 28, 2026
US Pre-Market SEC Filings Roundup — May 28, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals